BUSINESS
Drug regulator to include outside experts in review panels for complex therapies
Central Drugs Standard Control Organisation (CDSCO) chief Rajeev Singh Raghuvanshi has described the move as a 'very important milestone' necessary to keep pace with innovation
BUSINESS
Indian medical device makers prepare for US push, sensing opportunity from China tariffs
Some of the India medical devices companies have started work on regulatory filings and paperwork, to ensure they do not miss out on the opportunity emerging out of this tariff war.
BUSINESS
Weight-loss drugs offer hope, but no magic pill for obesity, say experts
Such medications are just one part of a necessary, holistic approach that includes diet, exercise, and addressing significant societal stigma, say experts.
BUSINESS
Natco Pharma aims to launch generic of Roche’s rare disease drug after favourable ruling in patent infringement case
The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to offer discount to certain deserving patients through its patient access programme.
BUSINESS
Lifestyle diseases striking younger in India warns Apollo Hospitals new report
The comprehensive study draws insights from de-identified electronic medical records encompassing over 2.5 million preventive health screenings conducted across Apollo’s vast ecosystem of hospitals, clinics, and diagnostic centres between 2019 and 2024.
BUSINESS
Trump tariffs to impact growth of Indian medical devices exports
According to Exports Promotion Council of Medical Devices, India's exports of medical devices to the US stood at $714.38 million, while imports from the US to India were significantly higher at $1.5 billion.
BUSINESS
Trump's move to exempt pharma from tariffs brings cheer to industry
The exemption applies broadly to all pharmaceutical products, ensuring that the drugmakers avoid immediate cost pressures
BUSINESS
Venkat Jasti’s billion-dollar gamble: Can Suven Life crack the CNS drug puzzle?
The Suven Life chairman is staking his fortune on a risky but potentially game-changing pipeline of central nervous system drugs, which are notoriously difficult to develop
BUSINESS
Gennova, CEPI ink pact to develop AI-enhanced Nipah vaccine with $13.4 million funding
At present, there is no approved vaccine or specific treatment exist for the virus, which has a mortality rate of 75 percent.
BUSINESS
FICCI caution members as US indict firms dealing in fentanyl precursors
The U.S. Department of Justice alleges that the companies facilitated the transportation, concealment, and sale of these substances within the US, in violation of federal law.
BUSINESS
Fentanyl: An explainer on the deadly opioid, Trump’s war and India's role
India with its vast pharmaceutical and chemical industries is an emerging source for fentanyl precursor chemicals. Mexican cartels purchase the precursors to make fentanyl which is shipped to the US.
BUSINESS
Delhi HC restrains Natco Pharma from launching generic of Roche's rare disease drug
"Roche has filed an appeal against the Hon. Delhi High Court order and the matter is subjudice in the appeal court," Roche Pharma India spokesperson told Moneycontrol.
BUSINESS
Less than 1% of health claims in India are for mental health, report reveals
The finding was part of Marsh McLennan’s "RiseUP for a Better Tomorrow" Mental Health Report 2025
BUSINESS
Eli Lilly’s weight loss drug remains expensive for most Indians despite local pricing
Unlike the US, Europe or other developed markets, Mounjaro will have to be purchased out-of-pocket in India, as obesity is yet to be officially recognised as a disease here. This also keeps it out of reach for the average Indian.
BUSINESS
Delhi HC denies stay against Natco Pharma, potentially paving way for affordable generic drug
The high court decision potentially opens the door for access to a generic version of the patented drug - Risdiplam - at a fraction of the cost marketed by the Swiss pharmaceutical major.
BUSINESS
Donald Trump may find himself in a bind on tariffs on generic drugs
Indian generics saved the US healthcare system $219 billion in 2022 and $1.3 trillion between 2013 and 2022, IQVIA has said
BUSINESS
Bharat Biotech launches $75 million cell & gene therapy facility in Hyderabad
“Bharat Biotech aims to democratize gene therapies, traditionally considered prohibitively expensive and available primarily in developed nations or premium institutions," Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said.
BUSINESS
Indian hospitals focus on other geographies as Bangladesh patient numbers decline
Hospital executives told Moneycontrol that there is a partial recovery in the number of medical visas issued to Bangladesh, even as they have stepped up targeted marketing and outreach efforts and introduced transparent packages to attract patients from other countries.
BUSINESS
Eli Lilly launches popular weight loss drug Mounjaro in India to tackle obesity and diabetes
The drug has seen strong demand in the US and Europe, and its India launch is part of Lilly’s broader strategy to expand access to innovative treatments in emerging markets.
BUSINESS
Entero Health acquires Aayu Chemist app, cloud platform MedCords to take on quick commerce rivals
Retail pharmacies in India are facing challenges from quick commerce players, which are reshaping consumer expectations with faster deliveries and digital-first experiences.
BUSINESS
Ambuja Neotia Group lines up Rs 2,000 crore investment in new hospitals, mother-childcare centres in East India
The expansion is being funded through internal accruals and debt. Neotia ruled out immediate equity fundraising, but left the door open for future capital infusion if a strategic acquisition opportunity arises.
BUSINESS
Global pharma giants Eli Lilly, Novo Nordisk launch obesity awareness campaigns, exploring India market potential
Novo and Lilly’s campaigns are not limited to advertisements alone, and both companies are trying to raise awareness around obesity through research studies and conferences.
BUSINESS
IPA rejects Ohio University study linking higher adverse events to made in India generics
IPA also refuted the study's reliance on the FDA Adverse Event Reporting System (FAERS) data, stating that FAERS data is observational and does not prove causation between drugs and adverse events.
BUSINESS
Prices of diabetes drug empagliflozin falls by 80-90% as generics enter market
Mankind Pharma, Alkem Laboratories, Glenmark, CORONA Remedies are some of the companies to have launched, making the drug affordable to most Indian patients
